Patients with breast cancer and no evidence of distant metastases with a diagnosis not longer than 91 days before study entry
Patients, who are able and willing to sign the informed consent form
Adult women aged ≥18 years
Patients with the diagnosis of invasive breast cancer (in German: Mammakarzinom, as op-posed to "non-invasive"= ductales Carcinoma in situ; irrespective of status of BC, e.g. TNM, re-ceptor status etc.) and
Patients, who are willing and able to sign the informed consent form
Patients with metastatic or locally advanced, inoperable disease proven by clinical measures (i.e. standard imaging)
You may not be if
Patients who did not sign the informed consent form
Clareo Health | Praegnant Breast Cancer: Early/Advanced/Metastatic
